EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.1.3.64 | Adenocarcinoma |
34241570 |
Targeting autophagy in disease: established and new strategies. |
causal interaction unassigned |
1 0 |
3.1.3.64 | Amyotrophic Lateral Sclerosis |
34241570 |
Targeting autophagy in disease: established and new strategies. |
causal interaction unassigned |
1 0 |
3.1.3.64 | Arthritis, Rheumatoid |
31444373 |
Association of MTMR3 rs12537 at miR-181a binding site with rheumatoid arthritis and systemic lupus erythematosus risk in Egyptian patients. |
diagnostic usage ongoing research unassigned |
2 2 0 |
3.1.3.64 | Azoospermia |
15557122 |
Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. |
causal interaction unassigned |
1 0 |
3.1.3.64 | Brain Diseases |
33843443 |
WDR45, one gene associated with multiple neurodevelopmental disorders. |
causal interaction unassigned |
1 0 |
3.1.3.64 | Breast Neoplasms |
31485632 |
MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 4 4 |
3.1.3.64 | Breast Neoplasms |
32531321 |
Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-?B signaling pathway. |
causal interaction therapeutic application unassigned |
2 1 0 |
3.1.3.64 | Breast Neoplasms |
34395483 |
rs12537 Is a Novel Susceptibility SNP Associated With Estrogen Receptor Positive Breast Cancer in Chinese Han Population. |
causal interaction diagnostic usage therapeutic application unassigned |
3 1 2 0 |
3.1.3.64 | Buruli Ulcer |
34424124 |
Inhibition of the SEC61 translocon by mycolactone induces a protective autophagic response controlled by EIF2S1-dependent translation that does not require ULK1 activity. |
ongoing research unassigned |
1 0 |
3.1.3.64 | Carcinogenesis |
20977678 |
Krebs medal review. How a lipid mediates tumour suppression: Delivered on 29 June 2010 at the 35th FEBS Congress in Gothenburg, Sweden. |
causal interaction diagnostic usage therapeutic application unassigned |
3 2 1 0 |